Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Michael Saerens
Profile
Projects
Publications
Activities
Awards & Distinctions
6
Results
2025
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
Michaël Henrotte
David Creytens
Filip De Vos
Benedicte Descamps
Lindsey Devisscher
Wouter Huvenne
Ken Kersemans
Sara Neyt
Sylvie Rottey
Michael Saerens
et al.
C3
Conference
2025
2024
Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer
Michael Saerens
Michel Struys
Wouter Huvenne
Sylvie Rottey
Fleur Cordier
S Fadei
David Creytens
W Waelput
Tijl Vermassen
Jens Debacker
C3
Conference
2024
2023
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus
Valérie Desmedt
Aranzazu Jauregui-Amezaga
Liselotte Fierens
Sandrine Aspeslagh
Jeroen Dekervel
Els Wauters
Marc Peeters
Joao Sabino
Lara Crape
Michael Somers
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2023
2022
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study
Emiel De Jaeghere
Heini Kanervo
Roos Colman
Wim Schrauwen
Paulien West
Nele Vandemaele
Aglaja De Pauw
Celine Jacobs
Ingeborg Hilderson
Michael Saerens
et al.
A1
Journal Article
in
CANCERS
2022
2021
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma : a systematic review and meta-analysis
Michael Saerens
Nele Brusselaers
Sylvie Rottey
Alexander Decruyenaere
David Creytens
Lore Lapeire
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2021
Risk of thrombo-embolic events in ovarian cancer : does bevacizumab tilt the scale? A systematic review and meta-analysis
Michael Saerens
Emiel De Jaeghere
Heini Kanervo
Nele Vandemaele
Hannelore Denys
Eline Naert
A1
Journal Article
in
CANCERS
2021